A citation-based method for searching scientific literature

Milena Tocut, Yehuda Shoenfeld, Gisele Zandman-Goddard. Expert Opin Investig Drugs 2020
Times Cited: 3







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Michael F Marmor, Ulrich Kellner, Timothy Y Y Lai, Ronald B Melles, William F Mieler. Ophthalmology 2016
459
66

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.
Lynda Bennett, A Karolina Palucka, Edsel Arce, Victoria Cantrell, Josef Borvak, Jacques Banchereau, Virginia Pascual. J Exp Med 2003
66

Type I Interferons in Autoimmune Disease.
Mary K Crow, Mikhail Olferiev, Kyriakos A Kirou. Annu Rev Pathol 2019
68
66

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Munther Khamashta, Joan T Merrill, Victoria P Werth, Richard Furie, Kenneth Kalunian, Gabor G Illei, Jorn Drappa, Liangwei Wang, Warren Greth. Ann Rheum Dis 2016
262
66

A possible early sign of hydroxychloroquine macular toxicity.
Livia M Brandao, Anja M Palmowski-Wolfe. Doc Ophthalmol 2016
7
33

Emergency clinicians' attitudes and decisions in patient scenarios involving advance directives.
Rebecca E Wong, Tracey J Weiland, George A Jelinek. Emerg Med J 2012
24
33

Chloroquine retinopathy in the rhesus monkey.
A R Rosenthal, H Kolb, D Bergsma, D Huxsoll, J L Hopkins. Invest Ophthalmol Vis Sci 1978
134
33


Drug-induced ocular disorders.
Junping Li, Ramesh C Tripathi, Brenda J Tripathi. Drug Saf 2008
106
33

Retinal toxicity in long term hydroxychloroquine treatment.
M Mavrikakis, S Papazoglou, P P Sfikakis, G Vaiopoulos, K Rougas. Ann Rheum Dis 1996
73
33

Ocular flare-up in patients with systemic lupus erythematosus following discontinuation of hydroxychloroquine.
Nazanin Ebrahimiadib, Hamid Riazi-Esfahani, Mostafa Heidari, Alireza Mahmoudi. Lupus 2020
1
100

Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice.
G D Levy, S J Munz, J Paschal, H B Cohen, K J Pince, T Peterson. Arthritis Rheum 1997
172
33

Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
Cassandra Doyno, Diana M Sobieraj, William L Baker. Clin Toxicol (Phila) 2021
7
33


Evaluation of Maculopathy in Patients Using Hydroxychloroquine
Adem Uğurlu, Maisa Aslanova, Zafer Cebeci, Nur Kır Mercül. Turk J Ophthalmol 2019
2
50

The role of photodegradation in the environmental fate of hydroxychloroquine.
Dario Dabić, Sandra Babić, Irena Škorić. Chemosphere 2019
9
33

Hydroxychloroquine in dermatology: New perspectives on an old drug.
Christopher Y Chew, Adrian Mar, Mandana Nikpour, Amanda M Saracino. Australas J Dermatol 2020
7
33

Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine.
Ji-Won Kim, Yoon Young Kim, Hwajeong Lee, Sung-Hoon Park, Seong-Kyu Kim, Jung-Yoon Choe. J Rheumatol 2017
18
33

Bull's-Eye Maculopathy Associated with Hydroxychloroquine.
Yasha S Modi, Rishi P Singh. N Engl J Med 2019
5
33

Corneal thickness and endothelial changes in long-term hydroxychloroquine use.
Tevfik Oğurel, Murat Atabey Özer, Yaprak Akbulut, Nesrin Büyüktortop Gökçınar, Zafer Onaran, Kemal Üreten. Cutan Ocul Toxicol 2019
3
33

The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
Ronald B Melles, Michael F Marmor. JAMA Ophthalmol 2014
261
33

Short-term, high-dose hydroxychloroquine corneal toxicity.
Daniel E Savage, Ronald Plotnik, Rachel A F Wozniak. Am J Ophthalmol Case Rep 2020
1
100

Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
Sebastián Ibáñez, Oriela Martínez, Francisca Valenzuela, Francisco Silva, Omar Valenzuela. Clin Rheumatol 2020
11
33



AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies.
Steffen Meyer, Martin Woodward, Christina Hertel, Philip Vlaicu, Yasmin Haque, Jaanika Kärner, Annalisa Macagno, Shimobi C Onuoha, Dmytro Fishman, Hedi Peterson,[...]. Cell 2016
128
33

Type I interferon correlates with serological and clinical manifestations of SLE.
M C Dall'era, P M Cardarelli, B T Preston, A Witte, J C Davis. Ann Rheum Dis 2005
191
33

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients.
Brandon W Higgs, Wei Zhu, Chris Morehouse, Wendy I White, Philip Brohawn, Xiang Guo, Marlon Rebelatto, Chenxiong Le, Anthony Amato, David Fiorentino,[...]. Ann Rheum Dis 2014
96
33

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.
L E Rönnblom, G V Alm, K E Oberg. Ann Intern Med 1991
423
33

Twenty-five years of type I interferon-based treatment: a critical analysis of its therapeutic use.
Guido Antonelli, Carolina Scagnolari, Federica Moschella, Enrico Proietti. Cytokine Growth Factor Rev 2015
29
33

Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases.
Jiao Jiang, Ming Zhao, Christopher Chang, Haijing Wu, Qianjin Lu. Clin Rev Allergy Immunol 2020
14
33

PROPERTIES AND FUNCTIONS OF THE NOVEL TYPE I INTERFERON EPSILON.
Zoe R C Marks, Nicole Campbell, Nicole A deWeerd, San S Lim, Linden J Gearing, Nollaig M Bourke, Paul J Hertzog. Semin Immunol 2019
3
33

A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1.
Lars Breivik, Bergithe E V Oftedal, Anette S Bøe Wolff, Eirik Bratland, Elizaveta M Orlova, Eystein S Husebye. Clin Immunol 2014
7
33

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yihong Yao, Laura Richman, Brandon W Higgs, Christopher A Morehouse, Melissa de los Reyes, Philip Brohawn, Jianliang Zhang, Barbara White, Anthony J Coyle, Peter A Kiener,[...]. Arthritis Rheum 2009
212
33

Toward better outcomes in Sjögren's syndrome: The promise of a stratified medicine approach.
Ghaith Noaiseh, Alan N Baer. Best Pract Res Clin Rheumatol 2020
4
33

Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
Kyriakos A Kirou, Christina Lee, Sandhya George, Kyriakos Louca, Ioannis G Papagiannis, Margaret G E Peterson, Ngoc Ly, Robert N Woodward, Kirk E Fry, Anna Yin-Har Lau,[...]. Arthritis Rheum 2004
283
33

[Systemic lupus erythematosus induced by recombinant alpha interferon treatment].
J Sánchez Román, M J Castillo Palma, E García Díaz, J A Ferrer Ordínez. Med Clin (Barc) 1994
10
33

Microarray analysis of interferon-regulated genes in SLE.
Mary K Crow, Kyriakos A Kirou, Jay Wohlgemuth. Autoimmunity 2003
206
33

Towards Precision Medicine in Systemic Lupus Erythematosus.
Elliott Lever, Marta R Alves, David A Isenberg. Pharmgenomics Pers Med 2020
9
33


The role of type I interferons and other cytokines in dermatomyositis.
Ashish Arshanapalli, Mihir Shah, Vindhya Veerula, Ally-Khan Somani. Cytokine 2015
21
33


IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study.
Frederic A Houssiau, Aikaterini Thanou, Minodora Mazur, Edgar Ramiterre, Danny Alexis Gomez Mora, Maria Misterska-Skora, Risto Alfredo Perich-Campos, Svetlana A Smakotina, Sergio Cerpa Cruz, Bassem Louzir,[...]. Ann Rheum Dis 2020
23
33

Anti-interferon alpha treatment in SLE.
Kyriakos A Kirou, Elena Gkrouzman. Clin Immunol 2013
81
33

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus.
Jeffrey M Riggs, Richard N Hanna, Bhargavi Rajan, Kamelia Zerrouki, Jodi L Karnell, Divya Sagar, Inna Vainshtein, Erika Farmer, Kimberly Rosenthal, Chris Morehouse,[...]. Lupus Sci Med 2018
32
33


The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells.
Sarah L Pogue, Benjamin T Preston, Joseph Stalder, Christopher R Bebbington, Pina M Cardarelli. J Interferon Cytokine Res 2004
46
33

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Joan T Merrill, Daniel J Wallace, Michelle Petri, Kyriakos A Kirou, Yihong Yao, Wendy I White, Gabriel Robbie, Robert Levin, Seth M Berney, Vishala Chindalore,[...]. Ann Rheum Dis 2011
172
33

Fine tuning type I interferon responses.
Paul J Hertzog, Bryan R G Williams. Cytokine Growth Factor Rev 2013
73
33

At least three human type alpha interferons: structure of alpha 2.
M Streuli, S Nagata, C Weissmann. Science 1980
273
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.